February 25, 2015
In this 2015 video, Dr. Gilks talks about CAP protocols for examining specimens from patients with endometrial cancer
Watch as Dr. Blake Gilks talks about CAP protocols for examining specimens of endometrium carcinoma. He covers the following topics in this session:
- Understanding the emerging importance of tumour site
- Looking at the differences between cervical stromal invasion and cervical mucosal implant, and the effects on staging
- Understanding problems with histotype assignment and how to diagnose mixed carcinomas
- Assessing depth of invasion in difficult settings
- Diagnosing MMR protein loss
- Noting recent developments in the genomics of endometrial carcinoma
Blake Gilks, MD, FRCPC is a Professor in the Department of Pathology and Laboratory Medicine at the University of British Columbia (BC) in Vancouver, BC, Canada. He does clinical service work in the Division of Anatomic Pathology at Vancouver General Hospital, where he is Regional Medical Director of Laboratories and Head of the Department of Pathology and Laboratory Medicine. In 1982, he graduated from Dalhousie University medical school in Halifax, Nova Scotia and did a residency in Anatomical Pathology at the University of British Columbia, followed by fellowships in Gynecological Pathology and Molecular Pathology at Massachusetts General Hospital and Fox Chase Cancer Center. Dr. Gilks is co-founder of the Genetic Pathology Evaluation Centre and OvCaRe, a multidisciplinary team studying ovarian cancer. He is also Co-Founder and Co-Director of the Canadian Immunohistochemistry Quality Control program.
Watch the video for the CAP education session about endometrial cancer
The Partnership, the Canadian Association of Pathologists (CAP-ACP) and Cancer Care Ontario (CCO) have organized this College of American Pathologists (CAP) education session.
In July 2009, the CAP-ACP endorsed the cancer protocols developed by CAP as the Canada-wide standard for all cancer-pathology reporting. To date, CAP protocols have been implemented in six Canadian provinces with the CAP-ACP’s support.
The protocols help pathologists to report effectively about diagnostic and prognostic findings, which are critical to patient care and the collection of collaborative stage data. The protocols were developed by multidisciplinary teams and are supported by CAP in both paper and electronic formats.